Adaptive regulation of endothelin receptor type-A and type-B in vascular smooth muscle cells during pregnancy in rats

Journal of Cellular Physiology

Volumn 229, Issue 4, 2014, Pages 489-501

  Ou, Minghui ^a,b   Dang, Yiping ^a   Mazzuca, Marc Q ^a   Basile, Rebecca ^a   Khalil, Raouf A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b People's Hospital of Ningxia Hui   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; MESSENGER RNA; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; PHENYLEPHRINE; POTASSIUM CHLORIDE; SARAFOTOXIN; SUCCINYLENDOTHELIN 1 [8-21][9 GLUTAMIC ACID 11,15 ALANINE];

ANIMAL CELL; AORTA MEDIA; ARTICLE; CELL ISOLATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INTIMA; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE FIBER; TISSUE DISTRIBUTION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASODILATATION; VIRGINITY; WESTERN BLOTTING;

EID: 84890503307     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24469     Document Type: Article

References (91)

1. Alexander BT, Rinewalt AN, Cockrell KL, Massey MB, Bennett WA, Granger JP. 2001. Endothelin type a receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure. Hypertension 37:485-489.
2. Bainbridge SA, Smith GN. 2005. HO in pregnancy. Free Radic Biol Med 38:979-988.
3. Cain AE, Tanner DM, Khalil RA. 2002. Endothelin-1-induced enhancement of coronary smooth muscle contraction via MAPK-dependent and MAPK-independent [Ca(2+)](i) sensitization pathways. Hypertension 39:543-549.
4. Conrad KP. 2011. Emerging role of relaxin in the maternal adaptations to normal pregnancy: Implications for preeclampsia. Semin Nephrol 31:15-32.
5. Conrad KP, Vernier KA. 1989. Plasma level, urinary excretion, and metabolic production of cGMP during gestation in rats. Am J Physiol 257:R847-R853.
6. Conrad KP, Whittemore SL. 1992. NG-monomethyl-l-arginine and nitroarginine potentiate pressor responsiveness of vasoconstrictors in conscious rats. Am J Physiol 262:R1137-1144.
7. Conrad KP, Kerchner LJ, Mosher MD. 1999. Plasma and 24-h NO(x) and cGMP during normal pregnancy and preeclampsia in women on a reduced NO(x) diet. Am J Physiol 277:F48-F57.
8. Crews JK, Novak J, Granger JP, Khalil RA. 1999. Stimulated mechanisms of Ca2+ entry into vascular smooth muscle during NO synthesis inhibition in pregnant rats. Am J Physiol 276:R530-R538.
9. Davidge ST, McLaughlin MK. 1992. Endogenous modulation of the blunted adrenergic response in resistance-sized mesenteric arteries from the pregnant rat. Am J Obstet Gynecol 167:1691-1698.
10. D'Orleans-Juste P, Labonte J, Bkaily G, Choufani S, Plante M, Honore JC. 2002. Function of the endothelin (B) receptor in cardiovascular physiology and pathophysiology. Pharmacol Ther 95:221-238.
11. Ekelund U, Adner M, Edvinsson L, Mellander S. 1994. Effects of selective ETB-receptor stimulation on arterial, venous and capillary functions in cat skeletal muscle. Br J Pharmacol 112:887-894.
12. Fellner SK, Arendshorst WJ. 2004. Endothelin A and B receptors of preglomerular vascular smooth muscle cells. Kidney Int 65:1810-1817.
13. Fukuroda T, Fujikawa T, Ozaki S, Ishikawa K, Yano M, Nishikibe M. 1994. Clearance of circulating endothelin-1 by ETB receptors in rats. Biochem Biophys Res Commun 199:1461-1465.
14. Fulep EE, Vedernikov YP, Saade GR, Garfield RE. 2001. The role of endothelium-derived hyperpolarizing factor in the regulation of the uterine circulation in pregnant rats. Am J Obstet Gynecol 185:638-642.
15. Gerber RT, Anwar MA, Poston L. 1998. Enhanced acetylcholine induced relaxation in small mesenteric arteries from pregnant rats: An important role for endothelium-derived hyperpolarizing factor (EDHF). Br J Pharmacol 125:455-460.
16. Goetz RM, Morano I, Calovini T, Studer R, Holtz J. 1994. Increased expression of endothelial constitutive nitric oxide synthase in rat aorta during pregnancy. Biochem Biophys Res Commun 205:905-910.
17. Honore JC, Fecteau MH, Brochu I, Labonte J, Bkaily G, D'Orleans-Juste P. 2005. Concomitant antagonism of endothelial and vascular smooth muscle cell ETB receptors for endothelin induces hypertension in the hamster. Am J Physiol Heart Circ Physiol 289:H1258-1264.
18. Hynynen MM, Khalil RA. 2006. The vascular endothelin system in hypertension-Recent patents and discoveries. Recent Patents Cardiovasc Drug Discov 1:95-108.
19. Ishikawa K, Ihara M, Noguchi K, Mase T, Mino N, Saeki T, Fukuroda T, Fukami T, Ozaki S, Nagase T, Nishikibe M, Yano M. 1994. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci USA 91:4892-4896.
20. Johnstrom P, Fryer TD, Richards HK, Harris NG, Barret O, Clark JC, Pickard JD, Davenport AP. 2005. Positron emission tomography using 18F-labelled endothelin-1 reveals prevention of binding to cardiac receptors owing to tissue-specific clearance by ET B receptors in vivo. Br J Pharmacol 144:115-122.
21. Kanashiro CA, Khalil RA. 1998. Signal transduction by protein kinase C in mammalian cells. Clin Exp Pharmacol Physiol 25:974-985.
22. Kanashiro CA, Altirkawi KA, Khalil RA. 2000. Preconditioning of coronary artery against vasoconstriction by endothelin-1 and prostaglandin F2alpha during repeated downregulation of epsilon-protein kinase C. J Cardiovasc Pharmacol 35:491-501.
23. Karne S, Jayawickreme CK, Lerner MR. 1993. Cloning and characterization of an endothelin-3 specific receptor (ETC receptor) from Xenopus laevis dermal melanophores. J Biol Chem 268:19126-19133.
24. Kedzierski RM, Yanagisawa M. 2001. Endothelin system: The double-edged sword in health and disease. Annu Rev Pharmacol Toxicol 41:851-876.
25. Khalil RA. 2011. Modulators of the vascular endothelin receptor in blood pressure regulation and hypertension. Curr Mol Pharmacol 4:176-186.
26. Khalil RA, Granger JP. 2002. Vascular mechanisms of increased arterial pressure in preeclampsia: Lessons from animal models. Am J Physiol Regul Integr Comp Physiol 283:R29-R45.
27. Khalil RA, van Breemen C. 1988. Sustained contraction of vascular smooth muscle: Calcium influx or C-kinase activation? J Pharmacol Exp Ther 244:537-542.
28. Khalil RA, Lajoie C, Resnick MS, Morgan KG. 1992. Ca(2+)-independent isoforms of protein kinase C differentially translocate in smooth muscle. Am J Physiol 263:C714-C719.
29. Khalil RA, Lajoie C, Morgan KG. 1994. In situ determination of [Ca2+]i threshold for translocation of the alpha-protein kinase C isoform. Am J Physiol 266:C1544-C1551.
30. Khalil RA, Morgan KG. 1991. Imaging of protein kinase C distribution and translocation in living vascular smooth muscle cells. Circ Res 69:1626-1631.
31. Khalil RA, Crews JK, Novak J, Kassab S, Granger JP. 1998. Enhanced vascular reactivity during inhibition of nitric oxide synthesis in pregnant rats. Hypertension 31:1065-1069.
32. Ko EA, Park WS, Ko JH, Han J, Kim N, Earm YE. 2005. Endothelin-1 increases intracellular Ca(2 +) in rabbit pulmonary artery smooth muscle cells through phospholipase C. Am J Physiol Heart Circ Physiol 289:H1551-H1559.
33. LaDouceur DM, Flynn MA, Keiser JA, Reynolds E, Haleen SJ. 1993. ETA and ETB receptors coexist on rabbit pulmonary artery vascular smooth muscle mediating contraction. Biochem Biophys Res Commun 196:209-215.
34. LaMarca BB, Cockrell K, Sullivan E, Bennett W, Granger JP. 2005. Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. Hypertension 46:82-86.
35. Lee DL, Webb RC, Jin L. 2004. Hypertension and RhoA/Rho-kinase signaling in the vasculature: Highlights from the recent literature. Hypertension 44:796-799.
36. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
37. Luscher TF, Barton M. 2000. Endothelins and endothelin receptor antagonists: Therapeutic considerations for a novel class of cardiovascular drugs. Circulation 102:2434-2440.
38. Ma Y, Qiao X, Falone AE, Reslan OM, Sheppard SJ, Khalil RA. 2010. Gender-specific reduction in contraction is associated with increased estrogen receptor expression in single vascular smooth muscle cells of female rat. Cell Physiol Biochem 26:457-470.
39. Mazzuca MQ, Khalil RA. 2012. Vascular endothelin receptor type B: Structure, function and dysregulation in vascular disease. Biochem Pharmacol 84:147-162.
40. Mazzuca MQ, Wlodek ME, Dragomir NM, Parkington HC, Tare M. 2010. Uteroplacental insufficiency programs regional vascular dysfunction and alters arterial stiffness in female offspring. J Physiol 588:1997-2010.
41. Mazzuca MQ, Dang Y, Khalil RA. 2013. Enhanced endothelin receptor type B-mediated vasodilation and underlying [Ca(2+)]i in mesenteric microvessels of pregnant rats. Br J Pharmacol 169:1335-1351.
42. McLaughlin BE, Hutchinson JM, Graham CH, Smith GN, Marks GS, Nakatsu K, Brien JF. 2000. Heme oxygenase activity in term human placenta. Placenta 21:870-873.
43. McMurdo L, Thiemermann C, Vane JR. 1994. The endothelin ETB receptor agonist, IRL 1620, causes vasodilatation and inhibits ex vivo platelet aggregation in the anaesthetised rabbit. Eur J Pharmacol 259:51-55.
44. McNair LL, Salamanca DA, Khalil RA. 2004. Endothelin-1 promotes Ca2+ antagonist-insensitive coronary smooth muscle contraction via activation of epsilon-protein kinase C. Hypertension 43:897-904.
45. Miasiro N, Karaki H, Paiva AC. 1998. Distinct endothelin-B receptors mediate the effects of sarafotoxin S6c and IRL1620 in the ileum. J Cardiovasc Pharmacol 31:S175-S178.
46. Miwa S, Kawanabe Y, Okamoto Y, Masaki T. 2005. Ca2+ entry channels involved in endothelin-1-induced contractions of vascular smooth muscle cells. J Smooth Muscle Res 41:61-75.
47. Molnar M, Hertelendy F. 1992. N omega-nitro-l-arginine, an inhibitor of nitric oxide synthesis, increases blood pressure in rats and reverses the pregnancy-induced refractoriness to vasopressor agents. Am J Obstet Gynecol 166:1560-1567.
48. Murphy JG, Khalil RA. 2000. Gender-specific reduction in contractility and [Ca(2+)](i) in vascular smooth muscle cells of female rat. Am J Physiol Cell Physiol 278:C834-C844.
49. Nakano D, Pollock JS, Pollock DM. 2008. Renal medullary ETB receptors produce diuresis and natriuresis via NOS1. Am J Physiol Renal Physiol 294:F1205-F1211.
50. Nakashima M, Vanhoutte PM. 1993. Endothelin-1 and -3 cause endothelium-dependent hyperpolarization in the rat mesenteric artery. Am J Physiol 265:H2137-H2141.
51. Nathan L, Cuevas J, Chaudhuri G. 1995. The role of nitric oxide in the altered vascular reactivity of pregnancy in the rat. Br J Pharmacol 114:955-960.
52. Nayler WG, Perry SE, Elz JS, Daly MJ. 1984. Calcium, sodium, and the calcium paradox. Circ Res 55:227-237.
53. Nishizuka Y. 1992. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607-614.
54. Novak J, Rajakumar A, Miles TM, Conrad KP. 2004. Nitric oxide synthase isoforms in the rat kidney during pregnancy. J Soc Gynecol Investig 11:280-288.
55. Nuedling S, van Eickels M, Allera A, Doevendans P, Meyer R, Vetter H, Grohe C. 2003. 17 Beta-estradiol regulates the expression of endothelin receptor type B in the heart. Br J Pharmacol 140:195-201.
56. Ohlstein EH, Arleth A, Bryan H, Elliott JD, Sung CP. 1992. The selective endothelin ETA receptor antagonist BQ123 antagonizes endothelin-1-mediated mitogenesis. Eur J Pharmacol 225:347-350.
57. Ohuchi T, Yanagisawa M, Gariepy CE. 2000. Renal tubular effects of endothelin-B receptor signaling: Its role in cardiovascular homeostasis and extracellular volume regulation. Curr Opin Nephrol Hypertens 9:435-439.
58. Okada M, Nishikibe M. 2002. BQ-788, a selective endothelin ET(B) receptor antagonist. Cardiovasc Drug Rev 20:53-66.
59. Oksche A, Boese G, Horstmeyer A, Furkert J, Beyermann M, Bienert M, Rosenthal W. 2000. Late endosomal/lysosomal targeting and lack of recycling of the ligand-occupied endothelin B receptor. Mol Pharmacol 57:1104-1113.
60. Osol G, Mandala M. 2009. Maternal uterine vascular remodeling during pregnancy. Physiology (Bethesda) 24:58-71.
61. Paasche JD, Attramadal T, Sandberg C, Johansen HK, Attramadal H. 2001. Mechanisms of endothelin receptor subtype-specific targeting to distinct intracellular trafficking pathways. J Biol Chem 276:34041-34050.
62. Pedersen SH, Nielsen LB, Pedersen NG, Nilas L, Ottesen B. 2009. Hormone therapy modulates ET(A) mRNA expression in the aorta of ovariectomised New Zealand White rabbits. Gynecol Endocrinol 25:175-182.
63. Peppiatt-Wildman CM, Albert AP, Saleh SN, Large WA. 2007. Endothelin-1 activates a Ca2+-permeable cation channel with TRPC3 and TRPC7 properties in rabbit coronary artery myocytes. J Physiol 580:755-764.
64. Pojoga LH, Williams JS, Yao TM, Kumar A, Raffetto JD, do Nascimento GR, Reslan OM, Adler GK, Williams GH, Shi Y, Khalil RA. 2011. Histone demethylase LSD1 deficiency during high-salt diet is associated with enhanced vascular contraction, altered NO-cGMP relaxation pathway, and hypertension. Am J Physiol Heart Circ Physiol 301:H1862-H1871.
65. Pollock DM, Jenkins JM, Cook AK, Imig JD, Inscho EW. 2005. L-type calcium channels in the renal microcirculatory response to endothelin. Am J Physiol Renal Physiol 288:F771-F777.
66. Risberg A, Olsson K, Lyrenas S, Sjoquist M. 2009. Plasma vasopressin, oxytocin, estradiol, and progesterone related to water and sodium excretion in normal pregnancy and gestational hypertension. Acta Obstet Gynecol Scand 88:639-646.
67. Roberts JM, Pearson G, Cutler J, Lindheimer M. 2003. Summary of the NHLBI Working Group on research on hypertension during pregnancy. Hypertension 41:437-445.
68. Sakamoto A, Yanagisawa M, Sawamura T, Enoki T, Ohtani T, Sakurai T, Nakao K, Toyo-oka T, Masaki T. 1993. Distinct subdomains of human endothelin receptors determine their selectivity to endothelin A-selective antagonist and endothelinB-selective agonists. J Biol Chem 268:8547-8553.
69. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T. 1990. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348:732-735.
70. Salamanca DA, Khalil RA. 2005. Protein kinase C isoforms as specific targets for modulation of vascular smooth muscle function in hypertension. Biochem Pharmacol 70:1537-1547.
71. Sand AE, Ostlund E, Andersson E, Fried G. 1998. Endothelin-induced contractions in placental arteries is mediated by both ETA- and ETB-receptors. Acta Physiol Scand 163:227-234.
72. Schiffrin EL. 2001. Role of endothelin-1 in hypertension and vascular disease. Am J Hypertens 14:83S-89S.
73. Schiffrin EL, Touyz RM. 1998. Vascular biology of endothelin. J Cardiovasc Pharmacol 32:S2-S13.
74. Schneider MP, Boesen EI, Pollock DM. 2007. Contrasting actions of endothelin ET(A) and ET(B) receptors in cardiovascular disease. Annu Rev Pharmacol Toxicol 47:731-759.
75. Schroeder AC, Imig JD, LeBlanc EA, Pham BT, Pollock DM, Inscho EW. 2000. Endothelin-mediated calcium signaling in preglomerular smooth muscle cells. Hypertension 35:280-286.
76. Seo B, Oemar BS, Siebenmann R, von Segesser L, Luscher TF. 1994. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 89:1203-1208.
77. Sirous ZN, Fleming JB, Khalil RA. 2001. Endothelin-1 enhances eicosanoids-induced coronary smooth muscle contraction by activating specific protein kinase C isoforms. Hypertension 37:497-504.
78. Sladek SM, Magness RR, Conrad KP. 1997. Nitric oxide and pregnancy. Am J Physiol 272:R441-R463.
79. Smith L, Payne JA, Sedeek MH, Granger JP, Khalil RA. 2003. Endothelin-induced increases in Ca2+ entry mechanisms of vascular contraction are enhanced during high-salt diet. Hypertension 41:787-793.
80. Somlyo AP, Somlyo AV. 2004. Signal transduction through the RhoA/Rho-kinase pathway in smooth muscle. J Muscle Res Cell Motil 25:613-615.
81. Stennett AK, Khalil RA. 2006. Neurovascular mechanisms of hypertension in pregnancy. Curr Neurovasc Res 3:131-148.
82. Stennett AK, Qiao X, Falone AE, Koledova VV, Khalil RA. 2009. Increased vascular angiotensin type 2 receptor expression and NOS-mediated mechanisms of vascular relaxation in pregnant rats. Am J Physiol Heart Circ Physiol 296:H745-H755.
83. Sumner MJ, Cannon TR, Mundin JW, White DG, Watts IS. 1992. Endothelin ETA and ETB receptors mediate vascular smooth muscle contraction. Br J Pharmacol 107:858-860.
84. Tirapelli CR, Casolari DA, Yogi A, Montezano AC, Tostes RC, Legros E, D'Orleans-Juste P, de Oliveira AM. 2005. Functional characterization and expression of endothelin receptors in rat carotid artery: Involvement of nitric oxide, a vasodilator prostanoid and the opening of K+ channels in ETB-induced relaxation. Br J Pharmacol 146:903-912.
85. Tostes RC, David FL, Carvalho MH, Nigro D, Scivoletto R, Fortes ZB. 2000. Gender differences in vascular reactivity to endothelin-1 in deoxycorticosterone-salt hypertensive rats. J Cardiovasc Pharmacol 36:S99-S101.
86. Touyz RM, Deng LY, Schiffrin EL. 1995a. Endothelin subtype B receptor-mediated calcium and contractile responses in small arteries of hypertensive rats. Hypertension 26:1041-1045.
87. Touyz RM, Lariviere R, Schiffrin EL. 1995b. Endothelin receptor subtypes in mesenteric vascular smooth muscle cells of spontaneously hypertensive rats. Can J Physiol Pharmacol 73:1262-1273.
88. Verhaar MC, Strachan FE, Newby DE, Cruden NL, Koomans HA, Rabelink TJ, Webb DJ. 1998. Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade. Circulation 97:752-756.
89. Williams DL, Jr., Jones KL, Pettibone DJ, Lis EV, Clineschmidt BV. 1991. Sarafotoxin S6c: An agonist which distinguishes between endothelin receptor subtypes. Biochem Biophys Res Commun 175:556-561.
90. Yener T, Turkkani Tunc A, Aslan H, Aytan H, Cantug Caliskan A. 2007. Determination of oestrous cycle of the rats by direct examination: How reliable? Anat Histol Embryol 36:75-77.
91. Ylikorkala O, Pekonen F, Viinikka L. 1986. Renal prostacyclin and thromboxane in normotensive and preeclamptic pregnant women and their infants. J Clin Endocrinol Metab 63:1307-1312.